Investor Update, page-147

The commotion surround this broker report has allowed me to accumulate at levels I had not expected, I want to thank the brokers for their favour.

The 500 mil additional shares to be issued in hypothesis would not pass existing shareholder approval.
Company can raise 15% plus an additional 10%, nowhere near enough almost 50 % as mentioned in report.
Why would we require nearly 8 mil working capital at this point?
The investor presentation forward looking statement mentions projected agreement with one collaborator to enter material development by end of second quarter, that is June this year.
Why would a CR of such measure be necessary when one can clearly assume share price to be multiples of today's level with such announcement under management's belt?
Our management is experienced and surely would believe their own projections.

Adding to that, also projected for second quarter, we expect first orders and partners secured in China for Anteobind.


Working capital of 8 mil dollars to last another 3 months?


I do expect an entity to join the board, become substantial holder on manipulated average prices, but such is the market.
I also expect that entity to join with conditions which, most likely, should surprise many here, reflecting an excellent IP position on our side.
That entity will have an improving share price in mind the minute they are in, IMO.

A public CR is highly unlikely, IMO.